𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effects of IL-6, alone and in combination with chemotherapeutic agents or radiotherapy, on the growth of human tumor xenografts

✍ Scribed by R Ruckser; O Schlappack; G Steinmetz; A Holm; E Liehl; N v Jeney


Book ID
119157378
Publisher
Elsevier Science
Year
1991
Weight
169 KB
Volume
27
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


CS-706, a novel cyclooxygenase-2 selecti
✍ Michiyo Senzaki; Saori Ishida; Ayumi Yada; Masaharu Hanai; Kosaku Fujiwara; Shin πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 176 KB

## Abstract The potent chemopreventive activity of cyclooxygenase‐2 (COX‐2) inhibitors has been demonstrated in a number of preclinical studies, but their potency in antitumor activity is still in dispute. In this report, we demonstrate the potent antitumor activity of a novel COX‐2 inhibitor, CS‐7

Effects of tumor necrosis factor, alone
✍ Giuseppe Giaccone; Chikabumi Kadoyama; Rhoda Maneckjee; David Venzon; Richard B. πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 French βš– 418 KB

## Abstract Tumor necrosis factor Ξ± (TNF) exhibits cytotoxic activity on some solid tumors and has been reported to be synergistic with topoisomerase‐II‐targeted antineoplastic agents. A wide range of TNF concentrations (from 10 to 10,000 U/ml) was tested in 9 human lung cancer cell lines (5 small‐

Effect of hyperthermia in combination wi
✍ Marco A. Alcala Jr.; Kyungsoo Park; Jinsang Yoo; Dae-Hee Lee; Bae-hang Park; Bye πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 385 KB πŸ‘ 1 views

## Abstract Approximately 25% of patients with colorectal cancer develop metastases to the liver, and surgery is currently the best treatment available. But there are several patients who are unresectable, and isolated hepatic perfusion (IHP) offers a different approach in helping to treat these pa

Grb2-SH3 ligand inhibits the growth of H
✍ Brunilde Gril; Michel Vidal; Franck Assayag; Marie-France Poupon; Wang-Qing Liu; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 633 KB

## Abstract HER2 represents an important signaling pathway in breast and other cancers. Herceptin has demonstrated clinical activity, but resistance is common. Thus, new therapeutic approaches to the HER2 pathway are needed. Grb2 is an adaptor protein involved in Ras‐dependent signaling induced by